QuidelOrtho Corp (QDEL)
39.55
+0.46
(+1.18%)
USD |
NASDAQ |
Nov 05, 16:00
39.55
0.00 (0.00%)
After-Hours: 19:17
QuidelOrtho Cash from Financing (Quarterly): 162.50M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 162.50M |
| March 31, 2024 | -18.50M |
| December 31, 2023 | -57.80M |
| September 30, 2023 | -48.70M |
| June 30, 2023 | -99.70M |
| March 31, 2023 | -59.60M |
| December 31, 2022 | -31.70M |
| September 30, 2022 | -126.00M |
| June 30, 2022 | 413.10M |
| March 31, 2022 | -3.40M |
| December 31, 2021 | -0.90M |
| September 30, 2021 | 1.80M |
| June 30, 2021 | -144.35M |
| March 31, 2021 | -29.65M |
| December 31, 2020 | -0.057M |
| September 30, 2020 | -43.20M |
| June 30, 2020 | -87.72M |
| March 31, 2020 | 0.705M |
| December 31, 2019 | -15.50M |
| September 30, 2019 | -5.957M |
| June 30, 2019 | -62.15M |
| March 31, 2019 | -14.68M |
| December 31, 2018 | -29.58M |
| September 30, 2018 | 2.476M |
| June 30, 2018 | -105.15M |
| Date | Value |
|---|---|
| March 31, 2018 | -111.80M |
| December 31, 2017 | 256.47M |
| September 30, 2017 | 9.89M |
| June 30, 2017 | 2.126M |
| March 31, 2017 | 2.121M |
| December 31, 2016 | 3.575M |
| September 30, 2016 | 2.546M |
| June 30, 2016 | 0.40M |
| March 31, 2016 | -23.32M |
| December 31, 2015 | -2.692M |
| September 30, 2015 | -14.51M |
| June 30, 2015 | -11.70M |
| March 31, 2015 | -0.356M |
| December 31, 2014 | 167.95M |
| September 30, 2014 | 1.006M |
| June 30, 2014 | 0.429M |
| March 31, 2014 | -1.326M |
| December 31, 2013 | 0.856M |
| September 30, 2013 | 1.117M |
| June 30, 2013 | 1.001M |
| March 31, 2013 | -1.184M |
| December 31, 2012 | -11.28M |
| September 30, 2012 | 1.373M |
| June 30, 2012 | 0.008M |
| March 31, 2012 | -27.61M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-144.35M
Minimum
Jun 2021
413.10M
Maximum
Jun 2022
-9.930M
Average
-29.65M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -1.576B |
| Becton Dickinson & Co | 1.119B |
| Repligen Corp | -5.773M |
| Perspective Therapeutics Inc | 122.08M |
| Xtant Medical Holdings Inc | 6.434M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -97.90M |
| Cash from Investing (Quarterly) | -35.30M |
| Free Cash Flow | -170.10M |
| Free Cash Flow Per Share (Quarterly) | -1.985 |
| Free Cash Flow to Equity (Quarterly) | -294.70M |
| Free Cash Flow to Firm (Quarterly) | -89.59M |
| Free Cash Flow Yield | -6.43% |